In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Second IPO attempt successful for TransMedics; nets $97.4mm

Executive Summary

TransMedics Group Inc. (device for organ procurement/transport) netted $97.4mm through its initial public offering of 6.5mm common shares (including the overallotment) at $16. When the company filed in April, it had planned to sell 4.7mm shares at a range of $15-17.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register